Center for Computational and Integrative Biology
Our Mission
Faculty in the Center for Computational and Integrative Biology (CCIB) apply interdisciplinary approaches and new technologies to answer enduring biological questions and provide insights into human disease. Novel chemical, genomics and computational tools are developed to probe signaling pathways, identify mediators of host-microbe interactions, and design therapeutic disease interventions. Center investigators also conduct translational research to explore the potential utility of early-stage drug candidates in phase 1 studies carried out in small populations of individuals with the target disease indication.
The CCIB provides support for investigators at Mass General Hospital and across the greater Boston area through a core that provides a wide range of high-quality, cutting-edge services in the areas of molecular biology, genomics and laboratory automation, and access to advanced instrumentation, methodologies and expertise.
News and Events
Register now for the third Gene Lay Institute Annual Symposium - Friday, July 31, 2026. Featuring an exciting lineup of speakers, including the 2025 Nobel Laureate Dr. Shimon Sakaguchi and incoming CCIB faculty Marco Colonna. More information and registration here.
Welcome Lucas! Lucas Meirelles has joined CCIB and the Center for Integrated Solutions for Infectious Diseases (CISID) as an Assistant Professor this year. The Meirelles lab works on lung pathogens and their role in long-term respiratory infections. We are excited for the collaborations and great science to come! Visit the lab at https://meirelleslab.org/
Congratulations Strecker! for receiving the 2025 NIH Director's New Innovator Award (DP2) to support a project on the discovery and characterization of programmable biological systems. Read more here.
Beyond Correlation: Toward Causal AI in Human Disease. Ashenberg and Xavier argue that while biological foundation models have transformed prediction across scales, their clinical impact has been limited by a reliance on correlations learned from observational data. In this commentary, the authors make the case for hybrid AI approaches that integrate deep learning with mechanistic and causal models, informed by interventional data from genetics and disease-relevant systems. Such models, they suggest, are essential for uncovering true disease mechanisms and enabling more effective therapeutic intervention. Read the article online to learn how causal modeling could shape the next generation of AI-driven biomedical discovery.
Gut Check: How the Microbiome Shapes Inflammation and Depression. A recent collaboration between investigators in CCIB and the HMS Blavatnik Institute revealed that the gut bacterium Morganella morganii may contribute to major depressive disorder by incorporating an environmental contaminant into a molecule that triggers inflammation. This contaminant could serve as a biomarker and supports links between depression and autoimmune processes. More information available in the HMS news story.
Publications
Klebsiella Brain Abscess and Evolution of Heterovirulence in the Urinary Tract. N Engl J Med. 2026;395(4):408-410
Prokaryotic Schlafen proteins cleave tRNAs during type III CRISPR immunity. Nat Commun. 2026;17(1):ePub
LINGO4 coordinates ILC3-intrinsic IL-22 production and microbiota-mediated ILC3 homeostasis. J Exp Med. 2026;223(6):ePub
Immunity in Alzheimer's disease: From mechanisms to therapies. mmunity. 2026;59(3):524-541
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy. Science. 2026;391(6789):eads3972
Divergent ILC3 responses to PDGF-D control mucosal immunity. Sci Immunol. 2026;11(116):eaea6848
RORγt+ dendritic cells are a distinct lymphoid-derived lineage. Sci Immunol. 2026;11(116):eaed7439
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity. Cell. 2026;189(5):1356-1370.e26
Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit. Nature. 2026;650(8103):997-1006
From nematode to Nobel: How community-shared resources fueled the rise of Caenorhabditis elegans as a research organism. Proc Natl Acad Sci U S A. 2025;122(48):e2522808122


